Kilter Group’s Nuvalent NUVL Stock Holding History

Kilter Group’s Portfolio NUVL Stock Details NUVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.84K	Buy	96 +93	+3,100%	+$9.48K	﹤0.01%	407
2025 Q4	$302	Buy	+3	New	+$296	﹤0.01%	1263

Other funds holding NUVL

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Kilter Group's NUVL Position: Q1 2026 in Review

Kilter Group increased its Nuvalent (NUVL) stake by 3,100% in Q1 2026, buying an estimated $9.48K and bringing the position to 96 shares worth $9.84K. The position accounts for ﹤0.01% of the portfolio, ranked #407.

Kilter Group first reported a position in NUVL in Q4 2025 and has held it in 2 quarters since. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

Kilter Group held 96 shares of Nuvalent worth $9.84K as of Q1 2026.
Kilter Group bought 93 Nuvalent shares in Q1 2026, an estimated $9.48K.
Nuvalent made up ﹤0.01% of Kilter Group's portfolio in Q1 2026, its #407 holding.
Kilter Group first reported a position in Nuvalent in Q4 2025 and has held it in 2 quarters since.
263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on Kilter Group's 13F filing for Q1 2026, filed 14 May 2026.